{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:00:13Z","timestamp":1792000813785,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The requirement for the immunoregulatory Mer tyrosine kinase (Mer) for optimal removal of apoptotic cells prompted us to look at its expression in systemic lupus erythematosus (SLE), in which apoptotic cell clearance is abnormal. We compared the levels of expression of Mer in normal human subjects and in patients with SLE.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We used flow cytometry of isolated peripheral blood mononuclear cells to compare the levels of Mer on leukocyte subsets. We used a Mer-specific enzyme-linked immunosorbent assay (ELISA) to quantify soluble Mer (sMer) in plasmas.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Monocytes, CD1c<jats:sup>+<\/jats:sup> myeloid dendritic cells (mDCs), and plasmacytoid dendritic cells (pDCs) from both normal individuals and from SLE patients expressed Mer. In both normal and SLE patients, the CD14<jats:sup>++<\/jats:sup>CD16<jats:sup>+<\/jats:sup> subpopulation of monocytes expressed the highest levels of Mer, with somewhat lower levels on the CD14<jats:sup>int<\/jats:sup>CD16<jats:sup>+<\/jats:sup> population. Mer levels on CD1c<jats:sup>+<\/jats:sup> mDCs and pDCs, and sMer levels in blood were increased in SLE patients compared with controls. In patients, Mer levels on CD14<jats:sup>int<\/jats:sup>CD16<jats:sup>+<\/jats:sup>, CD14<jats:sup>++<\/jats:sup>CD16<jats:sup>-<\/jats:sup> monocytes, and CD1c<jats:sup>+<\/jats:sup> dendritic cells correlated positively with type I interferon (IFN-I) activity detected in blood. In SLE patients treated with corticosteroids, Mer expression on monocytes correlated with prednisone dose, CD1c<jats:sup>+<\/jats:sup> myeloid dendritic cells in patients treated with prednisone had higher levels of Mer expression than those in patients not receiving prednisone.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>We found no global defect in Mer expression in lupus blood. In contrast, we observed increased levels of Mer expression in DC populations, which could represent a response to increased IFN-I in SLE patients. Enhanced Mer expression induced by corticosteroids may contribute to its beneficial effects in SLE.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4517","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T10:02:21Z","timestamp":1395396141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Brendan A","family":"Hilliard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehriban","family":"Ulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K","family":"Linan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0896-6273(91)90167-X","volume":"6","author":"C Lai","year":"1991","unstructured":"Lai C, Lemke G: An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron. 1991, 6: 691-704. 10.1016\/0896-6273(91)90167-X.","journal-title":"Neuron"},{"key":"4157_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1749-6632.2010.05744.x","volume":"1209","author":"G Lemke","year":"2010","unstructured":"Lemke G, Burstyn-Cohen T: TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci. 2010, 1209: 23-29. 10.1111\/j.1749-6632.2010.05744.x.","journal-title":"Ann N Y Acad Sci"},{"key":"4157_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35075603","volume":"411","author":"RS Scott","year":"2001","unstructured":"Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK: Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001, 411: 207-211. 10.1038\/35075603.","journal-title":"Nature"},{"key":"4157_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ni871","volume":"4","author":"HA Anderson","year":"2003","unstructured":"Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E: Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol. 2003, 4: 87-91.","journal-title":"Nat Immunol"},{"key":"4157_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1126\/science.1061663","volume":"293","author":"Q Lu","year":"2001","unstructured":"Lu Q, Lemke G: Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science (New York). 2001, 293: 306-311. 10.1126\/science.1061663.","journal-title":"Science (New York)"},{"key":"4157_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.coi.2010.10.001","volume":"22","author":"CV Rothlin","year":"2010","unstructured":"Rothlin CV, Lemke G: TAM receptor signaling and autoimmune disease. Curr Opin Immunol. 2010, 22: 740-746. 10.1016\/j.coi.2010.10.001.","journal-title":"Curr Opin Immunol"},{"key":"4157_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/blood-2006-04-017368","volume":"109","author":"P Sen","year":"2007","unstructured":"Sen P, Wallet MA, Yi Z, Huang Y, Henderson M, Mathews CE, Earp HS, Matsushima G, Baldwin AS, Tisch RM: Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood. 2007, 109: 653-660. 10.1182\/blood-2006-04-017368.","journal-title":"Blood"},{"key":"4157_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clim.2010.04.002","volume":"136","author":"WH Shao","year":"2010","unstructured":"Shao WH, Zhen Y, Rosenbaum J, Eisenberg RA, McGaha TL, Birkenbach M, Cohen PL: A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis. Clin Immunol (Orlando). 2010, 136: 236-244. 10.1016\/j.clim.2010.04.002.","journal-title":"Clin Immunol (Orlando)"},{"key":"4157_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1084\/jem.20051725","volume":"203","author":"MN Sharif","year":"2006","unstructured":"Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB: Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med. 2006, 203: 1891-1901. 10.1084\/jem.20051725.","journal-title":"J Exp Med"},{"key":"4157_CR10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V84.6.1931.1931","volume":"84","author":"A Neubauer","year":"1994","unstructured":"Neubauer A, Fiebeler A, Graham DK, O'Bryan JP, Schmidt CA, Barckow P, Serke S, Siegert W, Snodgrass HR, Huhn D: Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood. 1994, 84: 1931-1941.","journal-title":"Blood"},{"key":"4157_CR11","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.4049\/jimmunol.0804384","volume":"183","author":"S Scutera","year":"2009","unstructured":"Scutera S, Fraone T, Musso T, Cappello P, Rossi S, Pierobon D, Orinska Z, Paus R, Bulfone-Paus S, Giovarelli M: Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl\/Gas6 pathway. J Immunol. 2009, 183: 3004-3013. 10.4049\/jimmunol.0804384.","journal-title":"J Immunol"},{"key":"4157_CR12","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.4049\/jimmunol.178.9.5635","volume":"178","author":"HM Seitz","year":"2007","unstructured":"Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK: Macrophages and dendritic cells use different Axl\/Mertk\/Tyro3 receptors in clearance of apoptotic cells. J Immunology. 2007, 178: 5635-5642.","journal-title":"J Immunology"},{"key":"4157_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1165\/rcmb.2007-0306OC","volume":"39","author":"A Kazeros","year":"2008","unstructured":"Kazeros A, Harvey BG, Carolan BJ, Vanni H, Krause A, Crystal RG: Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers. Am J Respir Cell Mol Biol. 2008, 39: 747-757. 10.1165\/rcmb.2007-0306OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4157_CR14","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00134-013-3006-9","volume":"39","author":"C Guignant","year":"2013","unstructured":"Guignant C, Venet F, Planel S, Demaret J, Gouel-Cheron A, Nougier C, Friggeri A, Allaouchiche B, Lepape A, Monneret G: Increased MerTK expression in circulating innate immune cells of patients with septic shock. Intensive Care Med. 2013, 39: 1556-1564. 10.1007\/s00134-013-3006-9.","journal-title":"Intensive Care Med"},{"key":"4157_CR15","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1167\/iovs.08-3058","volume":"50","author":"DJ Strick","year":"2009","unstructured":"Strick DJ, Feng W, Vollrath D: Mertk drives myosin II redistribution during retinal pigment epithelial phagocytosis. Invest Ophthalmol Vis Sci. 2009, 50: 2427-2435. 10.1167\/iovs.08-3058.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4157_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11926-003-0061-1","volume":"5","author":"S Kuenkele","year":"2003","unstructured":"Kuenkele S, Beyer TD, Voll RE, Kalden JR, Herrmann M: Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance. Curr Rheumatol Rep. 2003, 5: 175-177. 10.1007\/s11926-003-0061-1.","journal-title":"Curr Rheumatol Rep"},{"key":"4157_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K","volume":"46","author":"I Baumann","year":"2002","unstructured":"Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M: Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46: 191-201. 10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K.","journal-title":"Arthritis Rheum"},{"key":"4157_CR18","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/art.11237","volume":"48","author":"Y Ren","year":"2003","unstructured":"Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS: Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003, 48: 2888-2897. 10.1002\/art.11237.","journal-title":"Arthritis Rheum"},{"key":"4157_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/ard.2005.037143","volume":"65","author":"SW Tas","year":"2006","unstructured":"Tas SW, Quartier P, Botto M, Fossati-Jimack L: Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis. 2006, 65: 216-221. 10.1136\/ard.2005.037143.","journal-title":"Ann Rheum Dis"},{"key":"4157_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H","volume":"41","author":"M Herrmann","year":"1998","unstructured":"Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1241-1250. 10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H.","journal-title":"Arthritis Rheum"},{"key":"4157_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI6801","volume":"104","author":"L Lu","year":"1999","unstructured":"Lu L, Kaliyaperumal A, Boumpas DT, Datta SK: Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest. 1999, 104: 345-355. 10.1172\/JCI6801.","journal-title":"J Clin Invest"},{"key":"4157_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10875-012-9743-7","volume":"32","author":"TA Gheita","year":"2012","unstructured":"Gheita TA, Bassyouni IH, Bassyouni RH: Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J Clin Immunol. 2012, 32: 1279-1286. 10.1007\/s10875-012-9743-7.","journal-title":"J Clin Immunol"},{"key":"4157_CR23","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/ar4199","volume":"15","author":"P Recarte-Pelz","year":"2013","unstructured":"Recarte-Pelz P, Tassies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG: Vitamin K-dependent proteins GAS6 and protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther. 2013, 15: R41-10.1186\/ar4199.","journal-title":"Arthritis Res Ther"},{"key":"4157_CR24","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar3088","volume":"12","author":"CH Suh","year":"2010","unstructured":"Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL: TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther. 2010, 12: R146-10.1186\/ar3088.","journal-title":"Arthritis Res Ther"},{"key":"4157_CR25","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/ar3316","volume":"13","author":"J Wu","year":"2011","unstructured":"Wu J, Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Gottsater A, Lindblad B, Lindqvist E, Saxne T, Dahlback B: Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis Res Ther. 2011, 13: R62-10.1186\/ar3316.","journal-title":"Arthritis Res Ther"},{"key":"4157_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI, a disease activity index for lupus patients: The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640. 10.1002\/art.1780350606.","journal-title":"Arthritis Rheum"},{"key":"4157_CR27","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB: Nomenclature of monocytes and dendritic cells in blood. Blood. 2010, 116: e74-e80. 10.1182\/blood-2010-02-258558.","journal-title":"Blood"},{"key":"4157_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","volume":"33","author":"J Cros","year":"2010","unstructured":"Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais JP, D'Cruz D, Casanova JL, Trouillet C: Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010, 33: 375-386. 10.1016\/j.immuni.2010.08.012.","journal-title":"Immunity"},{"key":"4157_CR29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","volume":"109","author":"S Sather","year":"2007","unstructured":"Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK: A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 2007, 109: 1026-1033.","journal-title":"Blood"},{"key":"4157_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/art.1780250407","volume":"25","author":"SR Ytterberg","year":"1982","unstructured":"Ytterberg SR, Schnitzer TJ: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 401-406. 10.1002\/art.1780250407.","journal-title":"Arthritis Rheum"},{"key":"4157_CR31","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/eji.200324076","volume":"33","author":"EM Behrens","year":"2003","unstructured":"Behrens EM, Gadue P, Gong SY, Garrett S, Stein PL, Cohen PL: The Mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur J Immunol. 2003, 33: 2160-2167. 10.1002\/eji.200324076.","journal-title":"Eur J Immunol"},{"key":"4157_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.clim.2009.06.002","volume":"133","author":"WH Shao","year":"2009","unstructured":"Shao WH, Zhen Y, Eisenberg RA, Cohen PL: The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol (Orlando). 2009, 133: 138-144. 10.1016\/j.clim.2009.06.002.","journal-title":"Clin Immunol (Orlando)"},{"key":"4157_CR33","doi-asserted-by":"publisher","first-page":"e21349","DOI":"10.1371\/journal.pone.0021349","volume":"6","author":"G Zahuczky","year":"2011","unstructured":"Zahuczky G, Kristof E, Majai G, Fesus L: Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages: role of Mertk in enhanced phagocytosis. PLoS One. 2011, 6: e21349-10.1371\/journal.pone.0021349.","journal-title":"PLoS One"},{"key":"4157_CR34","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo G, Hilliard BA, Monestier M, Cohen PL: Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunology. 2012, 189: 3508-3520. 10.4049\/jimmunol.1200662.","journal-title":"J Immunology"},{"key":"4157_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2013.00023","volume":"4","author":"L Ziegler-Heitbrock","year":"2013","unstructured":"Ziegler-Heitbrock L, Hofer TP: Toward a refined definition of monocyte subsets. Front Immunol. 2013, 4: 23-","journal-title":"Front Immunol"},{"key":"4157_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1515\/CCLM.1999.039","volume":"37","author":"JE Scherberich","year":"1999","unstructured":"Scherberich JE, Nockher WA: CD14++ monocytes, CD14+\/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med. 1999, 37: 209-213.","journal-title":"Clin Chem Lab Med"},{"key":"4157_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-3083.2007.02051.x","volume":"67","author":"J Skrzeczynska-Moncznik","year":"2008","unstructured":"Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J: Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol. 2008, 67: 152-159. 10.1111\/j.1365-3083.2007.02051.x.","journal-title":"Scand J Immunol"},{"key":"4157_CR38","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC: Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011, 118: e16-e31. 10.1182\/blood-2010-12-326355.","journal-title":"Blood"},{"key":"4157_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.33418","volume":"64","author":"M Rossol","year":"2012","unstructured":"Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U: The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 2012, 64: 671-677. 10.1002\/art.33418.","journal-title":"Arthritis Rheum"},{"key":"4157_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","volume":"32","author":"KS Rogacev","year":"2011","unstructured":"Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH: CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011, 32: 84-92. 10.1093\/eurheartj\/ehq371.","journal-title":"Eur Heart J"},{"key":"4157_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.ki.5002744","volume":"73","author":"GH Heine","year":"2008","unstructured":"Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, Krause M, Schlitt A, Kohler H, Girndt M: CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 2008, 73: 622-629. 10.1038\/sj.ki.5002744.","journal-title":"Kidney Int"},{"key":"4157_CR42","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"KS Rogacev","year":"2012","unstructured":"Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Grosse-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, B\u00f6hm M, Fliser D, Heine GH: CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012, 60: 1512-1520. 10.1016\/j.jacc.2012.07.019.","journal-title":"J Am Coll Cardiol"},{"key":"4157_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2567.2009.03087.x","volume":"128","author":"TP Mikolajczyk","year":"2009","unstructured":"Mikolajczyk TP, Skrzeczynska-Moncznik JE, Zarebski MA, Marewicz EA, Wisniewska AM, Dzieba M, Dobrucki JW, Pryjma JR: Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology. 2009, 128: 103-113. 10.1111\/j.1365-2567.2009.03087.x.","journal-title":"Immunology"},{"key":"4157_CR44","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/blood-2009-03-207522","volume":"114","author":"Z Yi","year":"2009","unstructured":"Yi Z, Li L, Matsushima GK, Earp HS, Wang B, Tisch R: A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells. Blood. 2009, 114: 3191-3198. 10.1182\/blood-2009-03-207522.","journal-title":"Blood"},{"key":"4157_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1084\/jem.20062293","volume":"205","author":"MA Wallet","year":"2008","unstructured":"Wallet MA, Sen P, Flores RR, Wang Y, Yi Z, Huang Y, Mathews CE, Earp HS, Matsushima G, Wang B, Tisch R: MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med. 2008, 205: 219-232. 10.1084\/jem.20062293.","journal-title":"J Exp Med"},{"key":"4157_CR46","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G: TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007, 131: 1124-1136. 10.1016\/j.cell.2007.10.034.","journal-title":"Cell"},{"key":"4157_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1126\/science.6176024","volume":"216","author":"OT Preble","year":"1982","unstructured":"Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J: Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (New York). 1982, 216: 429-431. 10.1126\/science.6176024.","journal-title":"Science (New York)"},{"key":"4157_CR48","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003, 100: 2610-2615. 10.1073\/pnas.0337679100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4157_CR49","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1002\/hep.23591","volume":"51","author":"AI Aspinall","year":"2010","unstructured":"Aspinall AI, Curbishley SM, Lalor PF, Weston CJ, Liaskou E, Adams RM, Holt AP, Adams DH: CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium. Hepatology (Baltimore). 2010, 51: 2030-2039. 10.1002\/hep.23591.","journal-title":"Hepatology (Baltimore)"},{"key":"4157_CR50","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1007\/s11033-012-1499-x","volume":"39","author":"S Garibaldi","year":"2012","unstructured":"Garibaldi S, Barisione C, Ghigliotti G, Spallarossa P, Barsotti A, Fabbi P, Corsiglia L, Palmieri D, Palombo D, Brunelli C: Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. Mol Biol Rep. 2012, 39: 6745-6752. 10.1007\/s11033-012-1499-x.","journal-title":"Mol Biol Rep"},{"key":"4157_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000327134","volume":"171","author":"R Ramirez","year":"2011","unstructured":"Ramirez R, Carracedo J, Merino A, Soriano S, Ojeda R, Alvarez-Lara MA, Martin-Malo A, Aljama P: CD14\u2009+\u2009CD16+ monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells. Contrib Nephrol. 2011, 171: 57-61.","journal-title":"Contrib Nephrol"},{"key":"4157_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1006\/jaut.1998.0215","volume":"11","author":"B Cederblad","year":"1998","unstructured":"Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Ronnblom L: Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmun. 1998, 11: 465-470. 10.1006\/jaut.1998.0215.","journal-title":"J Autoimmun"},{"key":"4157_CR53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1191\/096120301678416042","volume":"10","author":"S Blomberg","year":"2001","unstructured":"Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L: Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 2001, 10: 484-490. 10.1191\/096120301678416042.","journal-title":"Lupus"},{"key":"4157_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F: Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 2008, 58: 251-262. 10.1002\/art.23186.","journal-title":"Arthritis Rheum"},{"key":"4157_CR55","doi-asserted-by":"publisher","first-page":"R212","DOI":"10.1186\/ar4407","volume":"15","author":"G Zizzo","year":"2013","unstructured":"Zizzo G, Guerrieri J, Dittman LM, Merrill JT, Cohen PL: Circulating levels of soluble MER in lupus reflect M2c activation of monocytes\/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther. 2013, 15: R212-10.1186\/ar4407.","journal-title":"Arthritis Res Ther"},{"key":"4157_CR56","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1124\/jpet.112.199778","volume":"344","author":"JY Choi","year":"2013","unstructured":"Choi JY, Park HJ, Lee YJ, Byun J, Youn YS, Choi JH, Woo SY, Kang JL: Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. J Pharmacol Exp Ther. 2013, 344: 447-458. 10.1124\/jpet.112.199778.","journal-title":"J Pharmacol Exp Ther"},{"key":"4157_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.taap.2012.05.024","volume":"263","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Lee SH, Youn YS, Choi JY, Song KS, Cho MS, Kang JL: Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol Appl Pharmacol. 2012, 263: 61-72. 10.1016\/j.taap.2012.05.024.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4157_CR58","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.4049\/jimmunol.0803503","volume":"183","author":"A McColl","year":"2009","unstructured":"McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C, Dransfield I: Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol. 2009, 183: 2167-2175. 10.4049\/jimmunol.0803503.","journal-title":"J Immunol"},{"key":"4157_CR59","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","volume":"109","author":"J Ehrchen","year":"2007","unstructured":"Ehrchen J, Steinmuller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, Nordhues U, Sorg C, Sunderkotter C, Roth J: Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood. 2007, 109: 1265-1274.","journal-title":"Blood"},{"key":"4157_CR60","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1038\/bcj.2012.46","volume":"3","author":"LN Brandao","year":"2013","unstructured":"Brandao LN, Winges A, Christoph S, Sather S, Migdall-Wilson J, Schlegel J, McGranahan A, Gao D, Liang X, Deryckere D, Graham DK: Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia. Blood Cancer J. 2013, 3: e101-10.1038\/bcj.2012.46.","journal-title":"Blood Cancer J"},{"key":"4157_CR61","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1038\/sj.onc.1209633","volume":"25","author":"AK Keating","year":"2006","unstructured":"Keating AK, Salzberg DB, Sather S, Liang X, Nickoloff S, Anwar A, Deryckere D, Hill K, Joung D, Sawczyn KK, Park J, Curran-Everett D, McGavran L, Meltesen L, Gore L, Johnson GL, Graham DK: Lymphoblastic leukemia\/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene. 2006, 25: 6092-6100. 10.1038\/sj.onc.1209633.","journal-title":"Oncogene"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4517\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:13:10Z","timestamp":1728382390000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1186\/ar4517","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]},"assertion":[{"value":"27 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R76"}}